Charles River Laboratories Pre-Tax Profit Margin 2010-2024 | CRL

Current and historical pre-tax profit margin for Charles River Laboratories (CRL) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Charles River Laboratories pre-tax profit margin for the three months ending June 30, 2024 was .
Charles River Laboratories Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-06-30 $4.08B $0.54B 13.27%
2024-03-31 $4.11B $0.55B 13.38%
2023-12-31 $4.13B $0.58B 14.10%
2023-09-30 $4.22B $0.62B 14.66%
2023-06-30 $4.18B $0.63B 15.03%
2023-03-31 $4.09B $0.64B 15.72%
2022-12-31 $3.98B $0.62B 15.67%
2022-09-30 $3.78B $0.54B 14.33%
2022-06-30 $3.69B $0.54B 14.70%
2022-03-31 $3.63B $0.53B 14.46%
2021-12-31 $3.54B $0.48B 13.56%
2021-09-30 $3.43B $0.49B 14.24%
2021-06-30 $3.27B $0.50B 15.27%
2021-03-31 $3.04B $0.46B 15.02%
2020-12-31 $2.92B $0.45B 15.25%
2020-09-30 $2.82B $0.38B 13.46%
2020-06-30 $2.75B $0.32B 11.57%
2020-03-31 $2.72B $0.29B 10.76%
2019-12-31 $2.62B $0.30B 11.59%
2019-09-30 $2.53B $0.27B 10.78%
2019-06-30 $2.45B $0.27B 11.14%
2019-03-31 $2.38B $0.28B 11.95%
2018-12-31 $2.27B $0.28B 12.40%
2018-09-30 $2.14B $0.28B 12.84%
2018-06-30 $2.02B $0.28B 13.61%
2018-03-31 $1.91B $0.28B 14.80%
2017-12-31 $1.86B $0.30B 15.99%
2017-09-30 $1.85B $0.29B 15.82%
2017-06-30 $1.81B $0.27B 15.04%
2017-03-31 $1.77B $0.25B 14.04%
2016-12-31 $1.68B $0.22B 13.26%
2016-09-30 $1.57B $0.21B 13.32%
2016-06-30 $1.49B $0.21B 14.01%
2016-03-31 $1.40B $0.22B 15.38%
2015-12-31 $1.36B $0.20B 14.31%
2015-09-30 $1.34B $0.19B 13.82%
2015-06-30 $1.32B $0.18B 13.35%
2015-03-31 $1.32B $0.17B 12.66%
2014-12-31 $1.30B $0.18B 13.71%
2014-09-30 $1.26B $0.16B 12.81%
2014-06-30 $1.22B $0.16B 13.10%
2014-03-31 $1.17B $0.15B 12.45%
2013-12-31 $1.17B $0.14B 11.93%
2013-09-30 $1.16B $0.14B 12.28%
2013-06-30 $1.14B $0.13B 11.11%
2013-03-31 $1.14B $0.13B 11.45%
2012-12-31 $1.13B $0.13B 11.42%
2012-09-30 $1.14B $0.14B 11.92%
2012-06-30 $1.14B $0.13B 11.67%
2012-03-31 $1.14B $0.14B 11.90%
2011-12-31 $1.14B $0.13B 11.72%
2011-09-30 $1.13B $-0.27B -23.99%
2011-06-30 $1.13B $-0.31B -27.06%
2011-03-31 $1.13B $-0.33B -28.90%
2010-12-31 $1.13B $-0.34B -29.54%
2010-09-30 $1.12B $0.07B 6.00%
2010-06-30 $1.14B $0.12B 10.07%
2010-03-31 $1.16B $0.14B 12.06%
2009-12-31 $1.17B $0.15B 12.89%
Sector Industry Market Cap Revenue
Medical Medical Services $10.239B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $121.497B 14.81
Cencora (COR) United States $44.320B 16.94
ICON (ICLR) Ireland $23.561B 21.17
DiDi Global (DIDIY) China $23.282B 0.00
Avantor (AVTR) United States $17.560B 26.63
Natera (NTRA) United States $15.549B 0.00
Revvity (RVTY) United States $15.548B 27.23
Viatris (VTRS) United States $13.785B 4.20
CochLear (CHEOY) Australia $12.759B 0.00
Solventum (SOLV) United States $11.670B 0.00
Medpace Holdings (MEDP) United States $10.275B 31.18
Sonic Healthcare (SKHHY) Australia $9.066B 0.00
Doximity (DOCS) United States $7.965B 50.47
HealthEquity (HQY) United States $6.980B 37.88
Bausch + Lomb (BLCO) Canada $6.671B 28.71
PACS (PACS) United States $6.029B 0.00
Organon (OGN) United States $4.938B 5.02
Life Times (LTH) United States $4.827B 40.35
Sotera Health (SHC) United States $4.747B 23.94
Surgery Partners (SGRY) United States $4.058B 44.96
Concentras Parent (CON) United States $2.838B 0.00
Ardent Health Partners (ARDT) United States $2.613B 0.00
GoodRx Holdings (GDRX) United States $2.599B 97.86
BrightSpring Health Services (BTSG) United States $2.570B 0.00
Alignment Healthcare (ALHC) United States $2.194B 0.00
Premier (PINC) United States $2.003B 9.00
Ryman Healthcare (RYHTY) New Zealand $1.961B 0.00
AMN Healthcare Services Inc (AMN) United States $1.618B 8.12
CareDx (CDNA) United States $1.566B 0.00
Agilon Health (AGL) United States $1.539B 0.00
Progyny (PGNY) United States $1.517B 26.67
Teladoc Health (TDOC) United States $1.449B 0.00
Establishment Labs Holdings (ESTA) $1.314B 0.00
GeneDx Holdings (WGS) United States $1.153B 0.00
QDM (QDMI) Hong Kong, SAR China $1.123B 29.39
Pediatrix Medical (MD) United States $0.967B 10.52
Embecta (EMBC) United States $0.817B 5.45
InnovAge Holding (INNV) United States $0.812B 0.00
Auna S.A (AUNA) Luxembourg $0.531B 0.00
Sharecare (SHCR) United States $0.524B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.466B 0.00
Enhabit (EHAB) United States $0.399B 34.48
Sonida Senior Living (SNDA) United States $0.378B 0.00
DocGo (DCGO) United States $0.346B 13.00
Sera Prognostics (SERA) United States $0.256B 0.00
Biodesix (BDSX) United States $0.248B 0.00
LifeMD (LFMD) United States $0.224B 0.00
ModivCare (MODV) United States $0.200B 6.34
Ascend Wellness Holdings (AAWH) United States $0.181B 0.00
Beauty Health (SKIN) United States $0.171B 0.00
MultiPlan (MPLN) United States $0.118B 0.00
Nutex Health (NUTX) United States $0.099B 0.00
So-Young (SY) China $0.093B 22.49
Harvard Apparatus Regenerative Technology (HRGN) United States $0.087B 0.00
SBC Medicals (SBC) United States $0.050B 0.00
NeueHealth (NEUE) United States $0.042B 1.69
Co-Diagnostics (CODX) United States $0.039B 0.00
Singular Genomics Systems (OMIC) United States $0.039B 0.00
OncoCyte (OCX) United States $0.039B 0.00
Pheton Holdings (PTHL) China $0.032B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.031B 0.00
IceCure Medical (ICCM) Israel $0.029B 0.00
Oncology Institute (TOI) United States $0.023B 0.00
SeaStar Medical Holding (ICU) United States $0.018B 0.00
XWELL (XWEL) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
KindlyMD (KDLY) $0.007B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00